Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinflunine plus BSC vs BSC in Advanced Transitional Cell Carcinoma
NCT00315237Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Jul 2005
- Primary completion
- Jan 2008
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in urothelial carcinoma (UC) comparing Vinflunine + BSC with Best Supportive Care (2 arms). Primary endpoint: Overall Survival. Started Jul 2005; status: completed.
02
Drugs
vinflunine
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00315237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315237.